Pleural Effusion, Malignant: all 169 studies

Page 2 of 2. Open to participants first (39), then studies with results posted, then the rest; newest registration first within each.

• Activity Behaviours in Patients With Malignant Pleural EffusionStatus unknownNCT03482570
• Minirigid Versus Conventional Rigid Thoracoscopy in Undiagnosed Pleural EffusionsStatus unknownNCT03449602Not applicable
• Management of Malignant Pleural Effusions Using an Indwelling Tunneled Pleural Catheter and Non-Vacuum Collection SystemCompletedNCT03414905
• Rocket® Pleural Catheters: QOL, Feasibility and Satisfaction in Recurrent MPE PatientsStatus unknownNCT03403855Not applicable
• Intrapleural Docetaxel Administration Using Medical Pleuroscopy in Malignant Effusion With Lung CancerCompletedNCT03394105Phase 2
• Rapid Pleurodesis Through an Indwelling Pleural CatheterTerminatedNCT03325192Not applicable
• EDIT Management Feasibility TrialStatus unknownNCT03319186Not applicable
• Prognostic Factors on Malignant Pleural EffusionCompletedNCT03276715
• The Value of PET-CT in Pleural EffusionsCompletedNCT03272997
• The Added Value of CT Scanning in Patients With an Unilateral Pleural EffusionCompletedNCT03270215
• The Experiences of Patients Living With Malignant Pleural EffusionsCompletedNCT03235999
• Betadine Pleurodesis Via Tunneled Pleural CathetersWithdrawnNCT02975921Phase 4
• Bevacizumab in the Treatment of Malignant Pleural Effusions of Non-squamous Non-small Cell Lung CancerStatus unknownNCT02942043Phase 2
• Management of Malignant Pleural Effusion - Indwelling Pleural Catheter or Talc PleurodesisStatus unknownNCT02825095Early Phase 1
• Manometry vs Clinical Assessment in the Detection of Trapped Lung in Patients With Suspected Pleural MalignancyStatus unknownNCT02805062
• Photo-induction as a Means to Improve Cisplatin Delivery to Pleural MalignanciesTerminatedNCT02702700Phase 1
• Efficacy of Iodopovidone Versus Talc in Palliative Malignant Pleural EffusionCompletedNCT02674243Phase 3
• Clinical Trial of Tumor Cell-derived Microparticles Packaging Chemotherapeutic Drugs to Treat Malignant Pleural EffusionStatus unknownNCT02657460Phase 2
• Using Thoracic Ultrasound to Predict Pleurodesis Success in Malignant Pleural Effusions: a Pilot StudyCompletedNCT02625675
• A Study to Compare the Efficacy and Safety of Intrapleural Doxycycline Versus Iodopovidone for Performing Pleurodesis in Malignant Pleural EffusionCompletedNCT02583282Not applicable
• Out Patient Talc Slurry Via Indwelling Pleural Catheter for Malignant Pleural Effusion Vs Usual Inpatient ManagementCompletedNCT02517749Not applicable
• Recombinant Adenoviral Human p53 Gene in Treatment of Malignant Pleural EffusionStatus unknownNCT02429726Phase 2
• Cisplatin for Malignant Pleural Effusion in Patients With Non-small-cell Lung CancerStatus unknownNCT02407912Not applicable
• Intrapleural Bevacizumab After Pleural Drainage in the Context of Breast CancerTerminatedNCT02250118Phase 1
• A Pilot Study Evaluating the Safety and Effectiveness of a New Pleural Catheter for the Medical Management of Symptomatic, Recurrent, Malignant Pleural EffusionsCompletedNCT02227732Not applicable
• Efficacy and Safety Study of Abnoba Viscum F 20mg in Malignant Pleural Effusion PatientsCompletedNCT02191540Phase 3
• Combination Tissue Plasminogen Activator (Tpa) and Dornase Alfa (Dnase) Administration Through Intrapleural Catheters for the Treatment of Loculated or Non-Draining Malignant Pleural EffusionsStatus unknownNCT02135588Phase 1
• Efficacy and Safety of Bevacizumab Versus Pulvis Talci in Malignant Pleural EffusionStatus unknownNCT02054078Phase 2
• Intrapleural Bevacizumab Injection for Malignant Effusion in Lung CancerCompletedNCT02054052Phase 2
• Multicentre Study Comparing Indwelling Pleural Catheter With Talc Pleurodesis for Malignant Pleural Effusion ManagementStatus unknownNCT02045121Not applicable
• Intrapleural AdV-tk Therapy in Patients With Malignant Pleural EffusionCompletedNCT01997190Phase 1
• Safety and Effectiveness Study of Tumor Cell-derived Microparticles to Treat Malignant Ascites and Pleural EffusionStatus unknownNCT01854866Phase 2
• Relationship Between Pleural Elastance and Effectiveness of Pleurodesis on Recurrent Malignant Pleural EffusionStatus unknownNCT01819363
• Safety Profile of Iodopovidone as an Agent for Pleurodesis in Malignant Pleural EffusionCompletedNCT01670786Phase 4
• The Effect of Non-Steroidal Anti-Inflammatory Drug Naproxen on Pleural Effusion Formation After Lung ResectionTerminatedNCT01612975Phase 2
• Effectiveness of Doxycycline for Treating Pleural Effusions Related to Cancer in an Outpatient PopulationStatus unknownNCT01411202Phase 2
• Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or AscitesCompletedNCT01327235Phase 2
• Cediranib as Palliative Treatment in Patients With Symptomatic Malignant Ascites or Pleural EffusionTerminatedNCT01262612Phase 2
• Safety and Effectiveness Study for Pleurodesis With Silver Nitrate in Malignant Pleural EffusionStatus unknownNCT01125124Phase 2
• Pleural Catheters Versus Thoracoscopic PleurodesisCompletedNCT01117740
• Impact of Aggressive Versus Standard Drainage Regimen Using a Long Term Indwelling Pleural CatheterCompletedNCT00978939Phase 4
• Positron Emission Tomography and Computed Tomography in Planning Treatment for Patients Undergoing 3-Dimensional Conformal Radiation Therapy for Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery. ICORG 06-35TerminatedNCT00958321Phase 2
• Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial HyperplasiaStatus unknownNCT00899613
• Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung CancerWithdrawnNCT00897143
• The First Therapeutic Intervention in Malignant Pleural Effusion TrialCompletedNCT00896285Not applicable
• Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant MesotheliomaCompletedNCT00821860Phase 3
• Talc Pleurodesis in Patients With Recurrent Malignant Pleural EffusionCompletedNCT00789087Phase 4
• Intrapleural Catheter Daily Versus Three Times a Week DrainageActive, not recruitingNCT00761618Phase 2
• A Prospective, Randomized Controlled Trial for a Rapid Pleurodesis Protocol for the Management of Pleural EffusionsCompletedNCT00758316Phase 3
• Detection of EGFR Mutation in Malignant Pleural Effusion of Lung Cancer Patients and Cancer Cell Lines EstablishmentStatus unknownNCT00752076Not applicable
• Ibuprofen or Morphine in Treating Pain in Patients Undergoing Pleurodesis for Malignant Pleural EffusionStatus unknownNCT00644319Phase 2
• Tunneled Pleural Catheter in Partially Entrapped LungCompletedNCT00637676Phase 2
• BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00533585Phase 1
• A Comparative Study of the Safety and Efficacy of Face Talc Slurry and Iodopovidone for PleurodesisStatus unknownNCT00430664Not applicable
• Multiple Biomarkers in Undiagnosed Pleural EffusionTerminatedNCT00316134
• Comparison the Level of CTGF Protein and Related Cytokine in Pleural EffusionStatus unknownNCT00313066
• A Quality of Life Study re Management of Malignant Pleural EffusionsCompletedNCT00188474
• Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00118183Phase 2
• Surgery and Intrapleural Docetaxel in Treating Patients With Malignant Pleural EffusionCompletedNCT00114205Phase 1
• Non-small Cell Lung Cancer RegistryCompletedNCT00099541Phase 4
• Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural EffusionsCompletedNCT00066404Phase 1
• Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerCompletedNCT00052338Phase 1
• Standard Chest Tube Compared With a Small Catheter in Treating Malignant Pleural Effusion in Patients With CancerCompletedNCT00042770Phase 3
• Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the PleuraCompletedNCT00019825Phase 1
• Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerCompletedNCT00005842Phase 1
• ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous TreatmentWithdrawnNCT00005645Phase 2
• Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuCompletedNCT00004074Phase 1
• Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural EffusionsCompletedNCT00002872Phase 3
• Talc in Treating Patients With Malignant Pleural EffusionCompletedNCT00002622Phase 3

← Pleural Effusion, Malignant overview